Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

Articles

Will the CDF proposals force pharma to prepare for…

Pharma companies must start preparing its NICE submission at the time of making the regulatory subm…
Read more
Articles

Will Japan be the next country to adopt cost-effec…

The methodology to be used within the cost-effectiveness HTA evaluations is likely to be based on a …
Read more
Articles

Why should non-PMA professionals receive market ac…

Introduction Market Access is critical to commercial success, so the whole organisation needs to be …
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

Case Study
27.01.2023
Payer value proposition development

Payer value proposition development and understanding evidence requirements to secure pricing and re…

Read more
26.01.2023
What have we learned from the UK EAMS process?

Almost a decade after it’s inception, what have we learned from the UK early access to medicines sch…

Read more
Insider Insights
25.01.2023
UK to introduce first-of-its-kind framework to aid…

MHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin…

Read more
Insider Insights
25.01.2023
AstraZeneca/Daiichi Sankyo’s Enhertu has been re…

NICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce…

Read more
Insider Insights
25.01.2023
Singapore’s first global drug is being devel…

In a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys…

Read more
Insider Insights
25.01.2023
Biopharmas continue to offer hefty discounts to se…

Biopharmas offer significant discounts on their products in China, to try and score spots on the cou…

Read more
Insider Insights
24.01.2023
Takeda ready to file for TAK-755 enzyme replacemen…

Japan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy…

Read more
Insider Insights
23.01.2023
Germany – European joint assessment at deadlock …

Germany’s BPI and vfa advise that the implementation of the European Health Technology Assessment (E…

Read more
Insider Insights
17.01.2023
Abbvie and Eli Lilly withdraw from the UK drug pri…

Two global pharma companies withdraw from the UK’s Voluntary Scheme for Branded Medicines Pricing …

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.